The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 99%. Our forward projection puts the odds of a 10% gain over the next month near 18%. Insiders have been net buyers over the past quarter.
Ridgetech Inc RDGT
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Ridgetech, Inc.
read at $1.41
Ridgetech Inc holds its Distribution at $1.41.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · insiders bought, latest filing 2026-06-30
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 30 days |
| Price | $1.41 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | -0.19 |
The business, in plain words · what the numbers mean
| Revenue growth | -11.7% revenue is shrinking |
| Profit margin | 10.3% thin but positive margins |
| Return on equity | -8.0% not currently earning a positive return on equity |
| Debt to equity | 0.16 minimal debt — a conservative balance sheet |
| Current ratio | 1.82 healthy short-term liquidity |
| Beta | -0.19 barely tracks the market's swings |
| Market cap | $1M |
| Employees | 61 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to China and to currency swings; as a pharmaceutical retailers name, trial and regulatory outcomes can move it sharply either way.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in RDGT's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are down 99%. Our forward projection puts the odds of a 10% gain over the next month near 18%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Hrt Financial LP | 10% | Purchase | 41,136 | $69 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1.55 | +5.2% | · | $1,052 | +5.2% |
| 2 months | $2.52 | -35.3% | · | $647 | -35.3% |
| 3 months | $300.00 | -99.5% | · | $5 | -99.5% |
| 6 months | $586.50 | -99.7% | · | $3 | -99.7% |
| 1 year | $171.00 | -99.1% | · | $10 | -99.1% |
| 2 years | $403.50 | -99.6% | · | $4 | -99.6% |
| 3 years | $2,190.00 | -99.9% | · | $1 | -99.9% |
| 5 years | $35,640.00 | -100.0% | · | $0 | -100.0% |
Historical returns from market close data. Past performance does not guarantee future results.